Therapy Areas: Infectious Diseases
13 October 2021 - - The first patient has been dosed in the company's Phase 1 study of RPTR-168 (PRIME IL-12) in patients with select relapsed or refractory human papillomavirus -16-positive tumo...
13 October 2021 - Threat detection company Smiths Detection revealed on Wednesday that its BioFlash air sampler can detect the SARS-CoV-2 Alpha variant (B.1.1.7), Beta variant (B.1.351), Gamma variant...
12 October 2021 - - US-based digital health solutions company Quanterix Corp's (NASDAQ: QTRX) Simoa phospho-Tau 181 (pTau-181) blood test has been granted Breakthrough Device designation by ...
12 October 2021 - - US-based pharmaceutical company Merck (NYSE: MRK) has submitted an Emergency Use Authorization application to the US Food and Drug Administration for molnupiravir, an investigation...
8 October 2021 - - China, and US-based biotechnology company Brii Biosciences Ltd. (2137.HK) has filed an emergency use authorization application for its investigational SARS-CoV-2 (virus th...
8 October 2021 - - The US Food and Drug Administration approved Rethymic for the treatment of pediatric patients with congenital athymia, a rare immune disorder. Rethymic is the first thymus tiss...
Related Headlines